The company ranked No 1 worldwide in terms of its market share of
gene tumor diagnostic products for three consecutive years, after it
developed a research team led by a medical PhD Zhu Guanshan.
Haicang has organized a raft of biomedicine summits, forums and innovation and entrepreneurship competitions to increase the influence of its biomedicine industry.
Last year, the district invited 19 foreign senior experts from nine countries including the United States, Russia, Japan and Italy, via the national Recruitment Program of Global Experts, to visit local biomedical companies and startups to provide technological guidance.
Haicang invested nearly 1 billion yuan to build a biomedicine industry zone covering an area of 10 million square meters.
The zone is home to 30 research and public service centers, which provide about 90,000 services. It has more than 18,000 staff members, including 75 leading experts and 3,000 workers with senior technical titles.
The district also works with local commercial banks and the Xiamen Cross-Straits Equity Exchange Center to organize matchmaking events for biomedical companies, as well as project road shows and financial training courses.
The combined estimated value of its 97 local biomedical companies has almost reached 70 billion yuan.
China has launched a new pilot program to allow eligible enterprises greater access to overseas financing in support of green and low-carbon transformation projects, the country's foreign exchange regulator said on Aug 21.
To further streamline the experience, China is expanding tax refund stores, broadening the range of refundable goods, and refining refund procedures, ensuring an efficient and seamless shopping experience for global visitors.
